1-[3-(Dimethylamino)propyl]imidazolidine-2,4,5-trione hydrochloride

Catalog No.: 
ACEFFM477
CAS No.: 
1394042-21-7
Molecular Formula: 
C8H14ClN3O3
Molecular Weight: 
235.67
1-[3-(Dimethylamino)propyl]imidazolidine-2,4,5-trione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$242.00InquiryInquiry
100mg95%$349.00InquiryInquiry
250mg95%$490.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[3-(Dimethylamino)propyl]imidazolidine-2,4,5-trione hydrochloride
IUPAC Name1-(3-(dimethylamino)propyl)imidazolidine-2,4,5-trione hydrochloride
MDL No.MFCD22378738
Molecular FormulaC8H14ClN3O3
Molecular Weight235.67
SMILESO=C1NC(C(N1CCCN(C)C)=O)=O.[H]Cl
InChI KeyGLTQRVJBQJYEQS-UHFFFAOYSA-N
Synonym1-[3-(dimethylamino)propyl]imidazolidine-2,4,5-trione hydrochloride
CAS No.1394042-21-7

Synthetic Route by SureRoute

1. ACEFFM477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTNR452 route compound structure diagram
    ACBTNR4525407-04-5In Stock
  2. Plus
  3. ACVAXY648 route compound structure diagram
    ACVAXY648120-89-8In Stock
  4. Then
  5. ACEFFM477 route product structure diagram
    ACEFFM4771394042-21-7
Inquiry

2. ACEFFM477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVAXY648 route compound structure diagram
    ACVAXY648120-89-8In Stock
  4. Then
  5. ACEFFM477 route product structure diagram
    ACEFFM4771394042-21-7
Inquiry

3. ACEFFM477 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDIJ165 route compound structure diagram
    ACHDIJ1655845-30-7In Stock
  2. Plus
  3. ACVAXY648 route compound structure diagram
    ACVAXY648120-89-8In Stock
  4. Then
  5. ACEFFM477 route product structure diagram
    ACEFFM4771394042-21-7
Inquiry

Comments (0)